First Lady Auxillia Mnangagwa Appointed Health Ambassador

GOVERNMENT has  bestowed another special recognition to the First Lady Auxillia Mnangagwa appointing her the country’s Health and Child Care Ambassador for the role she plays in the country’s health sector. By Kudakwashe Pembere Last year she was made the Maternal and Child Health Ambassador. With her role in fighting cancer of the cervix,  she was made the Health Ambassador and she received a trophy. In her acceptance speech while accepting the new role, the First Lady said she takes this recognition as a challenge to work harder. “It is…

Share
Read More

“Our Salaries Are Now Useless”- Zim Nurses

THE prevailing economic crisis has not spared the health sector employees whose living standards continue to deteriorate despite a salary increase of between 25% and 29% for all civil servants which was effected two months ago. By Michael Gwarisa Government proposed the increment as part of a $400 million cost of living adjustment for all civil servants following a series of industrial actions from government employees which include nurses and doctors. Speaking during the launch of the Nurses Now Zimbabwe program in Harare, Zimbabwe Nurses Association (ZINA) president, Mr Enoch…

Share
Read More

Natpharm Management Faces Chop

HEALTH and Child Care Minister,  Dr Obadiah Moyo has directed National Pharmaceutical Company (NatPharm) bosses to pull up their socks or face the chop. By Kudakwashe Pembere He said this at an emergency meeting with the management on Sunday. The meeting came as a result of the First Lady Auxillia Mnangagwa who expressed dismay last Friday at NatPharm where she found stock piles of medicines when district hospitals and clinics had none. The Health Minister in a no nonsense mood, banging the desk barking order after order, felt the NatPharm…

Share
Read More

Zim Commences DTG Drug Transition

DEPUTY Director HIV/AIDS and STIs in the ministry of health and child care (MoHCC), Dr Tsitsi Apollo says the country has already commenced its transition process from Tenovir/Lamuvidene/Efavirens to Dolutegravir (DTG), a first line regimen of Antiretroviral Therapy (ART) which has less side effected and a rapid viral suppression. By Michael Gwarisa The whole transition process will be completed come February 2020 and in the process, drugs such as Navirapine (NVP) will be phased out with indications on the ground confirming that healthcare providers have already been advised to limit…

Share
Read More